Conformis Inc
CIK:0001305773|SEC Filings
Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
|||
| Revenue | ||||||
| Total revenue | $ 13,023 | $ 15,295 | $ 25,860 | $ 30,846 | ||
| Cost of revenue | 11,189 | 9,835 | 18,923 | 19,645 | ||
| Gross profit | 1,834 | 5,460 | 6,937 | 11,201 | ||
| Operating expenses | ||||||
| Sales and marketing | 4,063 | 6,562 | 9,114 | 13,227 | ||
| Research and development | 2,158 | 3,958 | 4,616 | 8,437 | ||
| General and administrative | 7,918 | 7,693 | 14,941 | 17,026 | ||
| Total operating expenses | 14,139 | 18,213 | 28,671 | 38,690 | ||
| Loss from operations | (12,305) | (12,753) | (21,734) | (27,489) | ||
| Other income and expenses | ||||||
| Interest income | 6 | 14 | 15 | 31 | ||
| Interest expense | (668) | (453) | (1,305) | (904) | ||
| Foreign currency exchange transaction (loss) income | (13) | (2,432) | 455 | (3,259) | ||
| Total other expenses | (675) | (2,871) | (835) | (4,132) | ||
| Loss before income taxes | (12,980) | (15,624) | (22,569) | (31,621) | ||
| Income tax (benefit) provision | 31 | (100) | 13 | (66) | ||
| Net loss | $ (13,011) | $ (15,524) | $ (22,582) | $ (31,555) | ||
| Net loss per share - basic (in dollars per share) | [1] | $ (1.78) | $ (2.15) | $ (3.10) | $ (4.39) | |
| Net loss per share - diluted (in dollars per share) | [1] | $ (1.78) | $ (2.15) | $ (3.10) | $ (4.39) | |
| Weighted average common shares outstanding - basic (in shares) | [1] | 7,316,286 | 7,211,851 | 7,291,542 | 7,189,634 | |
| Weighted average common shares outstanding - diluted (in shares) | [1] | 7,316,286 | 7,211,851 | 7,291,542 | 7,189,634 | |
| Product | ||||||
| Revenue | ||||||
| Total revenue | $ 12,496 | $ 15,142 | $ 25,187 | $ 30,026 | ||
| Royalty and licensing | ||||||
| Revenue | ||||||
| Total revenue | $ 527 | $ 153 | $ 673 | $ 820 | ||
| ||||||